Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein

Journal of Virology

Volumn 72, Issue 4, 1998, Pages 3076-3081

  Kreil, Thomas R ^a   Maier, Elisabeth ^a   Fraiss, Sabine ^a   Eibl, Martha M ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Institute for Immunology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

EID: 0031923329     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.4.3076-3081.1998     Document Type: Article

References (41)

1. Bachmann, M. F., U. Kalinke, A. Althage, G. Freer, C. Burkhart, H. Roost, M. Aguet, H. Hengartner, and R. M. Zinkernagel. 1997. The role of antibody concentration and avidity in antiviral protection. Science 276: 2024-2027.
2. Brandriss, M. W., J. J. Schlesinger, E. E. Walsh, and M. Briselli. 1986. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. J. Gen. Virol. 67:229-234.
3. Conley, A. J., J. A. Kessler, L. J. Boots, P. M. Mckenna, W. A. Schleif, E. A. Emini, G. E. Mark, H. Katinger, E. K. Cobb, S. M. Lunceford, S. R. Rouse, and K. K. Murthy. 1996. The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. J. Virol. 70: 6751-6758.
4. Crooks, A. J., J. M. Lee, L. M. Easterbrook, A. V. Timofeev, and J. R. Stephenson. 1994. The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell. J. Gen. Virol. 75: 3453-3460.
5. D'Ambrosio, D., K. L. Hippen, S. A. Minskoff, I. Mellman, G. Pani, K. A. Siminovitch, and J. C. Cambier. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 268:293-297.
6. Dimmock, N. J. 1995. Update on the neutralisation of animal viruses. Rev. Med. Virol. 5:165-179.
7. Drake, M. E., and C. Ming. 1954. Gamma globulin in epidemic hepatitis: comparative value of two dosage levels, apparently near the minimal effective level. JAMA 155:1302.
8. Fan, W. F., and P. W. Mason. 1990. Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA. Virology 177:470-476.
9. Gibson, C. A., J. J. Schlesinger, and A. D. Barrett. 1988. Prospects for a virus non-structural protein as a subunit vaccine. Vaccine 6:7-9.
10. Green, M. S., D. Cohen, Y. Lerman, M. Sjogren, L. N. Binn, S. Zur, R. Slepon, G. Robin, C. Hoke, W. Bancroft, et al. 1993. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J. Infect. Dis. 168:740-743.
11. Heath, S. L., J. G. Tew, A. K. Szakal, and G. F. Burton. 1995. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377: 740-744. (Comments.)
12. Heinz, F. X. 1986. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:103-168.
13. Heinz, F. X., R. Berger, W. Tuma, and C. Kunz. 1983. A tropological and functional model of epitopes on the structural glycoproteins of tick-borne encephalitis virus defined by monoclonal antibodies. Virology 126:525-537.
14. Heinz, F. X., W. Tuma, and C. Kunz. 1981. Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins. Infect. Immun. 33:250-257.
15. Hemming, V. G., G. A. Prince, J. R. Groothuis, and G. R. Siber. 1995. Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin. Microbiol. Rev. 8:22-33.
16. Hofmann, H., W. Frisch-Niggemeyer, and C. Kunz. 1978. Protection of mice against tick-borne encephalitis by different classes of immunoglobulins. Infection 6:154-157.
17. Jacobs, S. C., J. R. Stephenson, and G. W. Wilkinson. 1992. High-level expression of the tick-borne encephalitis virus NS1 protien by using an adenovirus-based vector: protection elicited in a murine model. J. Virol. 66: 2086-2095.
18. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645-649.
19. Kreil, T. R., I. Burger, E. Attakpah, K. Olas, and M. M. Eibl. Passive protection reduces immunity resulting from simultaneaus immunization against tick-borne encephalitis virus. Vaccine, in press.
20. Kreil, T. R., and M. M. Eibl. 1995. Viral infection of macrophages profoundly alters requirments for induction of nitric oxide synthesis. Virology 212:174-178.
21. Kreil, T. R., and M. M. Eibl. 1997. Pre-and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model. J. Virol. 71:2921-2927.
22. Kreil, T. R., K. Zimmermann, I. Burger, E. Attakpah, J. W. Mannhalter, and M. M. Eibl. 1997. Detection of tick-borne encephalitis virus by sample transfer, plaque assay and strand-specific reverse transcriptase polymerase chain reaction: what do we detect? J. Virol. Methods 68:1-8.
23. Mathews, J. H., and J. T. Roehrig. 1984. Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saints Louis encephalitis virus by passive transfer with monoclonal antibodies. J. Immunol. 132:1533-1537.
24. Murphy, B. R., G. A. Prince, P. L. Collins, S. W. Hildreth, and P. R. Paradiso. 1991. Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV). Vaccine 9:185-185.
25. Niedrig, M., U. Klockmann, W. Lang, J. Roeder, S. Burk, S. Modrow, and G. Pauli. 1994. Monoclonal antibodies directed against tick-borne encephalitis virus with nuetralizing activity in vivo. Acta Virol. 38:141-149.
26. Phillpotts, R. J., J. R. Stephenson, and J. S. Porterfield. 1987. Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virus. Brief report. Arch. Virol. 93:295-301.
27. Plaimauer, B. Unpublished data.
28. Pryor, M. J., and P. J. Wright. 1993. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology 194:769-780.
29. Ravetch, J. V., and J. P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9: 457-492.
30. Robbins, J. B., R. Schneerson, and S. C. Szu. 1995. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
31. Roehrig, J. T. 1986. The use of monoclonal antibodies in studies of the structural proteins of togaviruses and flaviviruses, p. 251-278. In S. Schlesinger and M. J. Schlesinger (ed.), The Togaviridae and Flaviviridae. Plenum Press, New York, N. Y.
32. + cytotoxic T lymphocytes. J. Virol. 67:801-806.
33. Rowley, D. A., F. W. Fitch F. P. Stuart, H. Kohler, and H. Cosenza. 1973. Specific suppression of immune responses. Science 181:1133-1141.
34. Schesinger, J. J., M. W. Brandriss, J. R. Putnak and E. E. Walsh. 1990. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequeces of interaction with antibody. J. Gen. Virol. 71:593-559.
35. Schlesinger, J. J., M. Foltzer, and S. Chapman. 1993. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192:132-141.
36. Schneider, A. J., and J. W. Mosley. 1959. Studies of variations of glutamic-oxaloacetic transaminase in the serum in infectious hepatitis. Pediatrics 24: 367-377.
37. Schumacher, C. L., H. C. Ertl, H. Koprowski, and B. Dietzschold. 1992. Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens. Vaccine 10:754-760.
38. Wengler, G., D. W. Bradley, M. S. Collett, F. X. Heinz, R. W. Schlesinger, and J. H. Strauss. 1995. Flaviviridae, p. 415-427. In F. A. Murphy, C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.), Virus taxonomy. Classification and nomenclature of viruses. Sixth report of the International Committee on Taxonomy of Viruses. Springer-Verlag, New York, N.Y.
39. Winkler, G., S. E. Maxwell, C. Ruemmler, and V. Stollar. 1989. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology 171:302-305.
40. Winkler, G., V. B. Randolph, G. R. Cleaves, T. E. Ryan, and V. Stollar 1988. Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology 162:187-196.
41. Winokur, P. L., and J. T. Stapleton. 1992. Immunoglobulin prophylaxis for hepatitis A. Clin. Infect. Dis. 14:580-586.